Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06753864 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Single-center, Open, Randomized, Single-dose, Cross-over Bioequivalence Study to Evaluate the Effects of the Test Formulation Abalparatide Injection and the Reference Formulation Abalparatide Injection (Tymlos®) in Healthy Adult Subjects

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 31, 2024 (before its estimated January 9, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
To investigate the pharmacokinetics of the test preparation abalparatide injection and the reference preparation abalparatide injection (Tymlos®) in healthy adult subjects under fasting state, and to evaluate the bioequivalence of the two formulations under fasting state.
Trial Details
NCT Number NCT06753864
Lead Sponsor The Affiliated Hospital of Qingdao University
Conditions
(from sponsor)		 Osteoporosis
Related terms Osteoporosis
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov